Shoamanesh A, Mundl H, Smith EE et al (2022) Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial
This treatment is derived from natural sources, which lowers the risk of side effects
Comparison table This table reinforces a critical point
In previous years, the concept of metabolic reprogramming has garnered attention in the field of cancer therapy
Thakkinstian A, Han P, McEvoy M, Smith W, Hoh J, Magnusson K, et al
Benefits: Embrace a supplement that not only promises but delivers a spectrum of health and aesthetic benefits